Hypotension (Low Blood Pressure) In rare cases, GHK-Cu may cause a slight drop in blood pressure, leading to mild dizziness or lightheadedness
Target: Reach about 300 mcg per dose by weeks 512, staying near the ~100 mcg per-dose GH-response ceiling
With no human trials and no FDA approval, it remains strictly experimental
Cerebrolysin is especially well-suited for post-concussion syndrome, post-viral cognitive impairment, traumatic brain injury recovery, and early neurodegenerative changes conditions where the brain has experienced significant stress or damage and needs meaningful support to recover
For an 80 kg test subject, this would give a weekly dosage range of between 2,400-4,800 g (2.4 4.8 mg)